Table 1.
Bio-humoral data of subjects (M/F) before and after COVID-19 lockdown
Baseline | After COVID-19 lockdown | |||||
---|---|---|---|---|---|---|
M | F | P | M | F | P | |
Glycemia (mg/dl) | 106 (83–138) | 108 (83–140) | 0.91 | 102 (82–144) | 109 (88–144) | 0.01 |
Insulinemia (microUI/ml) | 18 (11–27) | 16 (10–28) | 0.46 | 16 (10–32) | 23 (10–33) | < 0.0001 |
Cholesterol (mg/dl) | 174 (134–240) | 179 (136–241) | 0.81 | 180 (130–256) | 186 (130–263) | 0.08 |
LDL (mg/dl) | 110 (72–166) | 111 (70–168) | 0.51 | 109 (72–167) | 116 (66–173) | 0.33 |
HDL Cholesterol (mg/dl) | 40 (32–51) | 42 (32–52) | 0.002 | 40 (32–51) | 41.3 ± 4.6 | 0.33 |
Triglycerides (mg/dl) | 125 (55–265) | 129 (45–320) | 0.87 | 130 (40–305) | 170 (55–360) | 0.03 |
ALT (U/L) | 43.5 (23–89) | 45 (23–96) | 0.45 | 44 (25–112) | 52 (25–114) | 0.029 |
AST (U/L) | 38 (20–72) | 38 (18–78) | 0.81 | 38 (18–88) | 44 (20–98) | 0.04 |
GGT (U/L) | 32 (20–68) | 30 (20–73) | 0.01 | 32 (22–124) | 32 (20–108) | 0.44 |
P Difference between Males and Females (Unpaired T test)